These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 34203002)

  • 1. Probiotics, Prebiotics, and Synbiotics: Implications and Beneficial Effects against Irritable Bowel Syndrome.
    Simon E; Călinoiu LF; Mitrea L; Vodnar DC
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34203002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Probiotics, Prebiotics and Synbiotics in the Treatment of Irritable Bowel Syndrome: A systematic review and meta-analysis.
    Asha MZ; Khalil SFH
    Sultan Qaboos Univ Med J; 2020 Feb; 20(1):e13-e24. PubMed ID: 32190365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics, Prebiotics, and Synbiotics in the Irritable Bowel Syndrome Treatment: A Review.
    Chlebicz-Wójcik A; Śliżewska K
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Wu Y; Li Y; Zheng Q; Li L
    Nutrients; 2024 Jul; 16(13):. PubMed ID: 38999862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome.
    Ford AC; Harris LA; Lacy BE; Quigley EMM; Moayyedi P
    Aliment Pharmacol Ther; 2018 Nov; 48(10):1044-1060. PubMed ID: 30294792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY
    J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692
    [No Abstract]   [Full Text] [Related]  

  • 8. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
    Ooi SL; Correa D; Pak SC
    Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
    König J; Brummer RJ
    Benef Microbes; 2014 Sep; 5(3):247-61. PubMed ID: 24583610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
    Distrutti E; Monaldi L; Ricci P; Fiorucci S
    World J Gastroenterol; 2016 Feb; 22(7):2219-41. PubMed ID: 26900286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis.
    Ford AC; Quigley EM; Lacy BE; Lembo AJ; Saito YA; Schiller LR; Soffer EE; Spiegel BM; Moayyedi P
    Am J Gastroenterol; 2014 Oct; 109(10):1547-61; quiz 1546, 1562. PubMed ID: 25070051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
    Quigley EM
    Gastroenterol Clin North Am; 2011 Mar; 40(1):207-22. PubMed ID: 21333908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased microglial activation through gut-brain axis by prebiotics, probiotics, or synbiotics effectively restored cognitive function in obese-insulin resistant rats.
    Chunchai T; Thunapong W; Yasom S; Wanchai K; Eaimworawuthikul S; Metzler G; Lungkaphin A; Pongchaidecha A; Sirilun S; Chaiyasut C; Pratchayasakul W; Thiennimitr P; Chattipakorn N; Chattipakorn SC
    J Neuroinflammation; 2018 Jan; 15(1):11. PubMed ID: 29316965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why Use Nutraceutical Strategies for the Irritable Bowel Syndrome?
    di Michele F
    Curr Med Chem; 2022; 29(12):2075-2092. PubMed ID: 34533437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review.
    Smith KS; Greene MW; Babu JR; Frugé AD
    Nutr Neurosci; 2021 Dec; 24(12):963-977. PubMed ID: 31858898
    [No Abstract]   [Full Text] [Related]  

  • 17. GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.
    Barengolts E
    Endocr Pract; 2016 Oct; 22(10):1224-1234. PubMed ID: 27409822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symbiotics in irritable bowel syndrome--better than probiotics alone?
    Gracie DJ; Ford AC
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):485-9. PubMed ID: 26107141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives.
    Vallianou N; Stratigou T; Christodoulatos GS; Tsigalou C; Dalamaga M
    Curr Obes Rep; 2020 Sep; 9(3):179-192. PubMed ID: 32472285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.